Join us for an insightful conversation at the cross-roads of the economy, public health, and cutting-edge life sciences research. Harry Nelson, leading healthcare and life science attorney, will lead a discussion with Dr. Matthew Fienup, of California Lutheran University’s award-winning Center for Economic Research & Forecasting (CERF) and David Meline, CFO, of Moderna, one of the first companies globally to receive approval for a COVID-19 vaccine.
When: February 17, 2021 5:00 PM – 6:15 PM PST
Matthew Fienup, Ph.D
Center for Economic Research & Forecasting (CERF), California Lutheran University
Matthew Fienup is Executive Director of the Center for Economic Research & Forecasting (CERF) at California Lutheran University and teaches graduate courses in the school’s Master of Quantitative Economics Program. Matthew’s specialties are applied econometric analysis, the economics of land use, and environmental markets. Matthew is a member of the Wall Street Journal Economic Forecasting Survey. He was the recipient of a 2019 Crystal Ball Award for the Zillow Home Price Expectations Survey (formerly the Case-Schiller Home Price Expectations Survey). CERF’s U.S. home price forecast received multiple top-5 rankings among the more than 100 forecasts included in the survey. He is frequently sought to speak on the issues surrounding urban growth restriction and groundwater management policies as well as the general economic outlook for the Nation, the State and the region.
Chief Financial Officer (CFO)
David Meline is Chief Financial Officer (CFO) of Moderna, Inc. Meline joined Moderna in June, 2020, coming out of retirement from Amgen where he served as CFO and EVP from 2014 through 2019. Prior to Amgen, Meline was senior vice president and chief financial officer at 3M. Before joining 3M, Meline had been at General Motors, serving in various capacities including vice president and chief financial officer for GM North America. He had also held senior-level positions with GM Europe in Switzerland, GM Daewoo in South Korea, GM Brasil, GM Kenya, and at GM’s New York office in the company’s treasurer’s office. He is also member of the board of directors of ABB (ASEA Brown Boveri), the Los Angeles Philharmonicm, and the Dean’s Executive Council at California Lutheran University. He holds a Bachelor of Science in mechanical engineering from Iowa State University, a Master of Science in economics from the London School of Economics, London, United Kingdom, and an MBA in finance from the University of Chicago.
Co-Founding & Managing Partner
Nelson Hardiman LLP
Harry Nelson has been recognized as one of the leading healthcare and life science attorneys in America. He is the founder of Nelson Hardiman, a law firm that provides regulatory/transactional and litigation services. Harry is author of the best-selling The United States of Opioids: A Prescription for Liberating a Nation in Painand From ObamaCare to TrumpCare: Why You Should Care. Harry is known both for his work on regulatory and reimbursement pathway and strategy in areas of healthcare innovation, as well as for responding to industry crises and investigations. He consults regularly with healthcare and life science organizations, investors, and government authorities concerning the most difficult questions confronting the healthcare and life science industries.